Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yesid Alvarado

Showing results (1-10 of 117) with videos related to

Pageof 12
Sort By:
Expert Opinion on Emerging Drugs|July 3, 2007
Ras as a therapeutic target in hematologic malignanciesYesid Alvarado, Francis J Giles
Clinical Lymphoma & Myeloma|March 27, 2007
Novel Abl kinase inhibitors in chronic myeloid leukemia in blastic phase and Philadelphia chromosome-positive acute lymphoblastic leukemiaRonan Swords, Yesid Alvarado, Francis Giles
Annals of Hematology|September 15, 2023
A case of sudden hearing loss in a patient with chronic myelomonocytic leukemiaRodrick Babakhanlou, Marc-Elie Nader, Yesid Alvarado
Expert Review of Anticancer Therapy|March 22, 2003
Evolving role of ribonucleoside reductase inhibitors in hematologic malignanciesApostolia-Maria Tsimberidou, Yesid Alvarado, Francis J Giles
Hematology (Amsterdam, Netherlands)|July 10, 2003
Oral mucositis: time for more studiesYesid Alvarado, Lisa A Bellm, Francis J Giles
Expert Review of Hematology|January 26, 2012
The PIM kinases in hematological cancersYesid Alvarado, Francis J Giles, Ronan T Swords
The American Journal of the Medical Sciences|June 17, 2005
Troponin I elevation in a patient with acute severe bronchospasmFreddy Angulo, Yesid Alvarado, Warangkana Chokesuwattanaskul, et al.
Drugs|October 12, 2007
Treatment of acute lymphoblastic leukaemia : a new eraEffrosyni Apostolidou, Ronan Swords, Yesid Alvarado, et al.
Expert Opinion on Emerging Drugs|March 16, 2007
Emerging therapeutic options for Philadelphia-positive acute lymphocytic leukemiaYesid Alvarado, Effrosyni Apostolidou, Ronan Swords, et al.
Current Hematologic Malignancy Reports|April 29, 2010
Second-generation tyrosine kinase inhibitors as therapy for chronic myeloid leukemiaRonan Swords, Yesid Alvarado, Jorge Cortes, et al.
Pageof 12

Showing results (1-10 of 117) with videos related to

Sort By:
Pageof 12
Expert Opinion on Emerging Drugs|July 3, 2007
Ras as a therapeutic target in hematologic malignanciesYesid Alvarado, Francis J Giles
Clinical Lymphoma & Myeloma|March 27, 2007
Novel Abl kinase inhibitors in chronic myeloid leukemia in blastic phase and Philadelphia chromosome-positive acute lymphoblastic leukemiaRonan Swords, Yesid Alvarado, Francis Giles
Annals of Hematology|September 15, 2023
A case of sudden hearing loss in a patient with chronic myelomonocytic leukemiaRodrick Babakhanlou, Marc-Elie Nader, Yesid Alvarado
Expert Review of Anticancer Therapy|March 22, 2003
Evolving role of ribonucleoside reductase inhibitors in hematologic malignanciesApostolia-Maria Tsimberidou, Yesid Alvarado, Francis J Giles
Hematology (Amsterdam, Netherlands)|July 10, 2003
Oral mucositis: time for more studiesYesid Alvarado, Lisa A Bellm, Francis J Giles
Expert Review of Hematology|January 26, 2012
The PIM kinases in hematological cancersYesid Alvarado, Francis J Giles, Ronan T Swords
The American Journal of the Medical Sciences|June 17, 2005
Troponin I elevation in a patient with acute severe bronchospasmFreddy Angulo, Yesid Alvarado, Warangkana Chokesuwattanaskul, et al.
Drugs|October 12, 2007
Treatment of acute lymphoblastic leukaemia : a new eraEffrosyni Apostolidou, Ronan Swords, Yesid Alvarado, et al.
Expert Opinion on Emerging Drugs|March 16, 2007
Emerging therapeutic options for Philadelphia-positive acute lymphocytic leukemiaYesid Alvarado, Effrosyni Apostolidou, Ronan Swords, et al.
Current Hematologic Malignancy Reports|April 29, 2010
Second-generation tyrosine kinase inhibitors as therapy for chronic myeloid leukemiaRonan Swords, Yesid Alvarado, Jorge Cortes, et al.
Pageof 12